1. Home
  2. DSGX vs GRFS Comparison

DSGX vs GRFS Comparison

Compare DSGX & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Descartes Systems Group Inc. (The)

DSGX

Descartes Systems Group Inc. (The)

HOLD

Current Price

$67.60

Market Cap

6.2B

Sector

Technology

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$7.68

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSGX
GRFS
Founded
1981
1940
Country
Canada
Spain
Employees
N/A
25247
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
5.5B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
DSGX
GRFS
Price
$67.60
$7.68
Analyst Decision
Buy
Hold
Analyst Count
9
2
Target Price
$105.22
$10.15
AVG Volume (30 Days)
473.5K
590.7K
Earning Date
06-03-2026
07-28-2022
Dividend Yield
N/A
1.80%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.05
$4.49
Revenue Next Year
N/A
$6.42
P/E Ratio
$37.05
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$62.56
$7.39
52 Week High
$117.35
$11.14

Technical Indicators

Market Signals
Indicator
DSGX
GRFS
Relative Strength Index (RSI) 41.37 39.40
Support Level $62.69 $7.39
Resistance Level $75.06 $9.78
Average True Range (ATR) 2.33 0.22
MACD -0.71 -0.06
Stochastic Oscillator 22.23 16.06

Price Performance

Historical Comparison
DSGX
GRFS

About DSGX Descartes Systems Group Inc. (The)

Descartes Systems Group provides a software solution that allows users in the shipping industry to communicate with one another. Its core product is the Global Logistics Network, which is best understood as transaction-driven. Descartes charges clients to send/receive messages, data, and documents on the GLN. Customers typically contract for a monthly minimum over a multiyear period. The GLN platform allows Descartes to upsell additional software modules as well, typically provided via a software-as-a-service model.

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Share on Social Networks: